Cargando…
Disparities in Timeliness of Endometrial Cancer Care: A Scoping Review
OBJECTIVE: We use the person-centered Pathway to Treatment framework to assess the scope of evidence on disparities in endometrial cancer stage at diagnosis. This report is intended to facilitate interventions, research, and advocacy that reduce disparities. DATA SOURCES: We completed a structured s...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510803/ https://www.ncbi.nlm.nih.gov/pubmed/37734095 http://dx.doi.org/10.1097/AOG.0000000000005338 |
_version_ | 1785108021206056960 |
---|---|
author | Najor, Anna Melson, Valerie Lyu, Junrui Fadadu, Priyal Bakkum-Gamez, Jamie Sherman, Mark Kaunitz, Andrew Connor, Avonne Destephano, Christopher |
author_facet | Najor, Anna Melson, Valerie Lyu, Junrui Fadadu, Priyal Bakkum-Gamez, Jamie Sherman, Mark Kaunitz, Andrew Connor, Avonne Destephano, Christopher |
author_sort | Najor, Anna |
collection | PubMed |
description | OBJECTIVE: We use the person-centered Pathway to Treatment framework to assess the scope of evidence on disparities in endometrial cancer stage at diagnosis. This report is intended to facilitate interventions, research, and advocacy that reduce disparities. DATA SOURCES: We completed a structured search of electronic databases: PubMed, EMBASE, Scopus, ClinicalTrials.gov, and Cochrane Central Register of Controlled Trials databases. Included studies were published between January 2000 and 2023 and addressed marginalized population(s) in the United States with the ability to develop endometrial cancer and addressed variable(s) outlined in the Pathway to Treatment. METHODS OF STUDY SELECTION: Our database search strategy was designed for sensitivity to identify studies on disparate prolongation of the Pathway to Treatment for endometrial cancer, tallying 2,171. Inclusion criteria were broad, yet only 24 studies addressed this issue. All articles were independently screened by two reviewers. TABULATION, INTEGRATION, AND RESULTS: Twenty-four studies were included: 10 on symptom appraisal, five on help seeking, five on diagnosis, and 10 on pretreatment intervals. Quality rankings were heterogeneous, between 3 and 9 (median 7.2) per the Newcastle–Ottawa Scale. We identified three qualitative, two participatory, and two intervention studies. Studies on help seeking predominantly investigate patient-driven delays. When disease factors were controlled for, delays of the pretreatment interval were independently associated with racism toward Black and Hispanic people, less education, lower socioeconomic status, and nonprivate insurance. CONCLUSIONS: Evidence gaps on disparities in timeliness of endometrial cancer care reveal emphasis of patient-driven help-seeking delays, reliance on health care–derived databases, underutilization of participatory methods, and a paucity of intervention studies. SYSTEMATIC REVIEW REGISTRATION: Given that PROSPERO was not accepting systematic scoping review protocols at the time this study began, this study protocol was shared a priori through Open Science Framework on January 13, 2021 (doi: 10.17605/OSF.IO/V2ZXY), and through peer review publication on April 13, 2021 (doi: https://doi.org/10.1186/s13643-021-01649-x). |
format | Online Article Text |
id | pubmed-10510803 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-105108032023-09-21 Disparities in Timeliness of Endometrial Cancer Care: A Scoping Review Najor, Anna Melson, Valerie Lyu, Junrui Fadadu, Priyal Bakkum-Gamez, Jamie Sherman, Mark Kaunitz, Andrew Connor, Avonne Destephano, Christopher Obstet Gynecol Gynecology OBJECTIVE: We use the person-centered Pathway to Treatment framework to assess the scope of evidence on disparities in endometrial cancer stage at diagnosis. This report is intended to facilitate interventions, research, and advocacy that reduce disparities. DATA SOURCES: We completed a structured search of electronic databases: PubMed, EMBASE, Scopus, ClinicalTrials.gov, and Cochrane Central Register of Controlled Trials databases. Included studies were published between January 2000 and 2023 and addressed marginalized population(s) in the United States with the ability to develop endometrial cancer and addressed variable(s) outlined in the Pathway to Treatment. METHODS OF STUDY SELECTION: Our database search strategy was designed for sensitivity to identify studies on disparate prolongation of the Pathway to Treatment for endometrial cancer, tallying 2,171. Inclusion criteria were broad, yet only 24 studies addressed this issue. All articles were independently screened by two reviewers. TABULATION, INTEGRATION, AND RESULTS: Twenty-four studies were included: 10 on symptom appraisal, five on help seeking, five on diagnosis, and 10 on pretreatment intervals. Quality rankings were heterogeneous, between 3 and 9 (median 7.2) per the Newcastle–Ottawa Scale. We identified three qualitative, two participatory, and two intervention studies. Studies on help seeking predominantly investigate patient-driven delays. When disease factors were controlled for, delays of the pretreatment interval were independently associated with racism toward Black and Hispanic people, less education, lower socioeconomic status, and nonprivate insurance. CONCLUSIONS: Evidence gaps on disparities in timeliness of endometrial cancer care reveal emphasis of patient-driven help-seeking delays, reliance on health care–derived databases, underutilization of participatory methods, and a paucity of intervention studies. SYSTEMATIC REVIEW REGISTRATION: Given that PROSPERO was not accepting systematic scoping review protocols at the time this study began, this study protocol was shared a priori through Open Science Framework on January 13, 2021 (doi: 10.17605/OSF.IO/V2ZXY), and through peer review publication on April 13, 2021 (doi: https://doi.org/10.1186/s13643-021-01649-x). Lippincott Williams & Wilkins 2023-10 2023-09-07 /pmc/articles/PMC10510803/ /pubmed/37734095 http://dx.doi.org/10.1097/AOG.0000000000005338 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Gynecology Najor, Anna Melson, Valerie Lyu, Junrui Fadadu, Priyal Bakkum-Gamez, Jamie Sherman, Mark Kaunitz, Andrew Connor, Avonne Destephano, Christopher Disparities in Timeliness of Endometrial Cancer Care: A Scoping Review |
title | Disparities in Timeliness of Endometrial Cancer Care: A Scoping Review |
title_full | Disparities in Timeliness of Endometrial Cancer Care: A Scoping Review |
title_fullStr | Disparities in Timeliness of Endometrial Cancer Care: A Scoping Review |
title_full_unstemmed | Disparities in Timeliness of Endometrial Cancer Care: A Scoping Review |
title_short | Disparities in Timeliness of Endometrial Cancer Care: A Scoping Review |
title_sort | disparities in timeliness of endometrial cancer care: a scoping review |
topic | Gynecology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510803/ https://www.ncbi.nlm.nih.gov/pubmed/37734095 http://dx.doi.org/10.1097/AOG.0000000000005338 |
work_keys_str_mv | AT najoranna disparitiesintimelinessofendometrialcancercareascopingreview AT melsonvalerie disparitiesintimelinessofendometrialcancercareascopingreview AT lyujunrui disparitiesintimelinessofendometrialcancercareascopingreview AT fadadupriyal disparitiesintimelinessofendometrialcancercareascopingreview AT bakkumgamezjamie disparitiesintimelinessofendometrialcancercareascopingreview AT shermanmark disparitiesintimelinessofendometrialcancercareascopingreview AT kaunitzandrew disparitiesintimelinessofendometrialcancercareascopingreview AT connoravonne disparitiesintimelinessofendometrialcancercareascopingreview AT destephanochristopher disparitiesintimelinessofendometrialcancercareascopingreview |